Literature DB >> 14567916

Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control.

Barsanjit Mazumder1, Prabha Sampath, Vasudevan Seshadri, Ratan K Maitra, Paul E DiCorleto, Paul L Fox.   

Abstract

Transcript-specific translational control is generally directed by binding of trans-acting proteins to structural elements in the untranslated region (UTR) of the target mRNA. Here, we elucidate a translational silencing mechanism involving regulated release of an integral ribosomal protein and subsequent binding to its target mRNA. Human ribosomal protein L13a was identified as a candidate interferon-Gamma-Activated Inhibitor of Translation (GAIT) of ceruloplasmin (Cp) mRNA by a genetic screen for Cp 3'-UTR binding proteins. In vitro activity of L13a was shown by inhibition of target mRNA translation by recombinant protein. In response to interferon-gamma in vivo, the entire cellular pool of L13a was phosphorylated and released from the 60S ribosomal subunit. Released L13a specifically bound the 3'-UTR GAIT element of Cp mRNA and silenced translation. We propose a model in which the ribosome functions not only as a protein synthesis machine, but also as a depot for regulatory proteins that modulate translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567916     DOI: 10.1016/s0092-8674(03)00773-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  136 in total

1.  Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.

Authors:  Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-02-28       Impact factor: 4.396

2.  From cis-regulatory elements to complex RNPs and back.

Authors:  Fátima Gebauer; Thomas Preiss; Matthias W Hentze
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

3.  Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation.

Authors:  Jie Jia; Abul Arif; Belinda Willard; Jonathan D Smith; Dennis J Stuehr; Stanley L Hazen; Paul L Fox
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

Review 4.  Heterogeneity and specialized functions of translation machinery: from genes to organisms.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

5.  Growth inhibitory effects of large subunit ribosomal proteins in melanoma.

Authors:  Gregory R Kardos; Mu-Shui Dai; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-16       Impact factor: 4.693

6.  Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammation.

Authors:  Abhijit Basu; Darshana Poddar; Peggy Robinet; Jonathan D Smith; Maria Febbraio; William M Baldwin; Barsanjit Mazumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-16       Impact factor: 8.311

7.  Abiotic stress resistance, a novel moonlighting function of ribosomal protein RPL44 in the halophilic fungus Aspergillus glaucus.

Authors:  Xiao-Dan Liu; Lixia Xie; Yi Wei; Xiaoyang Zhou; Baolei Jia; Jinliang Liu; Shihong Zhang
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

Review 8.  The Discovery of Ribosome Heterogeneity and Its Implications for Gene Regulation and Organismal Life.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

9.  Functional specificity among ribosomal proteins regulates gene expression.

Authors:  Suzanne Komili; Natalie G Farny; Frederick P Roth; Pamela A Silver
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

10.  The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.

Authors:  Karthik A Ganapathi; Karyn M Austin; Chung-Sheng Lee; Anusha Dias; Maggie M Malsch; Robin Reed; Akiko Shimamura
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.